<DOC>
	<DOCNO>NCT02406261</DOCNO>
	<brief_summary>The purpose study study effect AZD3293 body absorbs process 3 medication , midazolam , simvastatin donepezil 3 medication affect AZD3293 take together . This study 2 group , group A approximately 44 day long group B 70 day . The screen visit require within 30 day prior start study</brief_summary>
	<brief_title>A Drug-drug Interaction Study AZD3293 ( LY3314814 ) Healthy Participants</brief_title>
	<detailed_description>Astra Zeneca ( AZ ) register trial sponsor . In July , 2015 , sponsorship change Eli Lilly Company ( Lilly ) . In August , 2015 , AZ transfer trial Lilly 's ClinicalTrials.gov account Lilly update record . This trial applicable trial Food Drug Administration Amendments Act 2007 ( FDAAA ) .</detailed_description>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Overtly healthy either sterile , male prepared use approve method contraception Have body mass index ( BMI ) screen 19.0 32.0 kilogram per square meter ( kg/m^2 ) History clinically significant disease disorder , opinion Investigator , may put subject risk participation study , may influence result , may limit subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug History previous ongoing psychiatric disease/condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>